Corteva Common (CTVA) closed at $12.26 on November 4, 2026, up 3.2% from the previous close, on volume of 20,227,150 shares (30-day average 27,698,310).
Data as of November 4, 2026.
4-Nov-2026
3M stock climbs to multi-year high on $7.35B 'forever chemicals' settlement
Seeking Alpha News (Thu, 5-Nov 12:37 AM ET)
3M to pay up to $7.35B to settle PFAS groundwater contamination lawsuits
Seeking Alpha News (Wed, 4-Nov 4:17 PM ET)
Universal Corporation Announces Appointment of Gregory R. Friedman to Board of Directors
Business Wire (Wed, 4-Nov 4:15 PM ET)
Corteva Declares Quarterly Dividend
PRNewswire (Fri, 23-Oct 8:00 AM ET)
Corteva Sets Nov. 11 Q3 2026 Earnings Release, With Webcast Replay Available for a Full Year
Market Chameleon (Wed, 7-Oct 6:59 AM ET)
Corteva Announces Dates for Third Quarter 2026 Earnings Release and Webcast
PRNewswire (Tue, 6-Oct 8:01 AM ET)
Corteva to Exit the S&P 500 After Vylor Spin-Off, Moving to the S&P MidCap 400 on Oct. 6
Market Chameleon (Fri, 2-Oct 7:02 AM ET)
PRNewswire (Thu, 1-Oct 6:01 PM ET)
Corteva Begins New Chapter as Focused, Innovation-Led, Global Crop Protection Leader
PRNewswire (Thu, 1-Oct 8:01 AM ET)
Market Chameleon (Thu, 1-Oct 3:36 AM ET)
Corteva is a crop protection pure play. The company was formed in 2019 when it was spun off from DowDuPont and spun off its seeds business, Vylor, in 2026. Corteva is a leader in the development of new crop protection products, including herbicides, insecticides, fungicides, biologicals, and plant health products. Corteva operates globally. North America generates nearly 40% of revenue while Latin America generates over 30%.
Corteva Common trades on the NYSE stock market under the symbol CTVA.
As of November 4, 2026, CTVA stock price climbed to $12.26 with 20,227,150 million shares trading.
CTVA has a beta of 0.37, meaning it tends to be less sensitive to market movements. CTVA has a correlation of 0.00 to the broad based SPY ETF.
CTVA has a market cap of $8.23 billion. This is considered a Mid Cap stock.
Last quarter Corteva Common reported $6 billion in Revenue and $2.30 earnings per share. This fell short of revenue expectation by $-209 million and exceeded earnings estimates by $.11.
In the last 3 years, CTVA traded as high as $90.97 and as low as $11.25.
The top ETF exchange traded funds that CTVA belongs to (by Net Assets): VTI, VOO, VO, VTV, VOE.
CTVA has underperformed the market in the last year with a price return of -79.1% while the SPY ETF gained +13.3%. CTVA has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -83.6% and -5.0%, respectively, while the SPY returned +1.5% and -0.3%, respectively.
CTVA support price is $11.57 and resistance is $12.19 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CTVA shares will trade within this expected range on the day.
